Search Results

There are 2557198 results for: content related to: Corrections: Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 5, May 2014, Pages: 1028–1034, Wai-Kay Seto, Yuk-Fai Lam, James Fung, Danny Ka-Ho Wong, Fung-Yu Huang, Ivan Fan-Ngai Hung, Ching-Lung Lai and Man-Fung Yuen

    Version of Record online : 21 APR 2014, DOI: 10.1111/jgh.12476

  3. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  4. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  5. You have free access to this content
    Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing

    Clinical Microbiology and Infection

    Volume 18, Issue 10, October 2012, Pages: E404–E411, S.-Y. Ko, H.-B. Oh, C.-W. Park, H. C. Lee and J.-E. Lee

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1469-0691.2012.03951.x

  6. You have free access to this content
    Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 11, June 2012, Pages: 1326–1335, G. L.-H. Wong, V. W.-S. Wong, H.-Y. Chan, P. C.-H. Tse, J. Wong, A. M.-L. Chim, K. K.-L. Yiu, S. H.-T. Chu and H. L.-Y. Chan

    Version of Record online : 16 APR 2012, DOI: 10.1111/j.1365-2036.2012.05098.x

  7. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 26–33, Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Belinda Mak, How Cheng Low, Kieron Lim, Maung Aye Thwin, Poh Seng Tan and Seng Gee Lim

    Version of Record online : 28 SEP 2012, DOI: 10.1002/jmv.23392

  8. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 892–898, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 30 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06161.x

  9. You have free access to this content
    Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 2001–2006, Christian M. Lange, Jörg Bojunga, Wolf Peter Hofmann, Katrin Wunder, Ulrike Mihm, Stefan Zeuzem and Christoph Sarrazin

    Version of Record online : 29 SEP 2009, DOI: 10.1002/hep.23346

  10. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy

    Journal of Viral Hepatitis

    Volume 21, Issue 8, August 2014, Pages: e55–e64, Chien-Hung Chen, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu and Chuan-Mo Lee

    Version of Record online : 28 APR 2014, DOI: 10.1111/jvh.12239

  11. Discovery and Development of Entecavir

    Antiviral Drugs: From Basic Discovery through Clinical Trials

    Richard Wilber, Bruce Kreter, Marc Bifano, Stephanie Danetz, Lois Lehman-McKeeman, Daniel J. Tenney, Nicholas Meanwell, Robert Zahler, Helena Brett-Smith, Pages: 401–416, 2011

    Published Online : 20 JUN 2011, DOI: 10.1002/9780470929353.ch28

  12. You have free access to this content
    Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B

    Hepatology

    Volume 63, Issue 2, February 2016, Pages: 377–387, Maureen M. Jonas, Mei-Hwei Chang, Etienne Sokal, Kathleen B. Schwarz, Deirdre Kelly, Kyung Mo Kim, Simon C. Ling, Philip Rosenthal, Dumitru Oraseanu, Laurie Reynolds, Alexandra Thiry and Peter Ackerman

    Version of Record online : 16 OCT 2015, DOI: 10.1002/hep.28015

    Corrected by:

    Corrections: Correction

    Vol. 65, Issue 4, 1427, Version of Record online: 3 MAR 2017

  13. You have free access to this content
    Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 422–430, Ting-Tsung Chang, Ching-Lung Lai, Seung Kew Yoon, Samuel S. Lee, Henrique Sergio M. Coelho, Flair Jose Carrilho, Fred Poordad, Waldemar Halota, Yves Horsmans, Naoky Tsai, Hui Zhang, Daniel J. Tenney, Ricardo Tamez and Uchenna Iloeje

    Version of Record online : 4 JAN 2010, DOI: 10.1002/hep.23327

  14. Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e41–e47, J. H. Kwon, J. W. Jang, S. Lee, J. Lee, K. W. Chung, Y. S. Lee and J. Y. Choi

    Version of Record online : 20 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01509.x

  15. You have full text access to this OnlineOpen article
    Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation

    Journal of Viral Hepatitis

    Volume 19, Issue 3, March 2012, Pages: 161–172, C.-C. Chen, P.-C. Wang, H.-W. Chang and C.-F. Chen

    Version of Record online : 4 JUL 2011, DOI: 10.1111/j.1365-2893.2011.01469.x

  16. You have free access to this content
    Posters (Abstracts 264–2239)

    Hepatology

    Volume 66, Issue S1, October 2017, Pages: 149–1185,

    Version of Record online : 1 OCT 2017, DOI: 10.1002/hep.29501

  17. Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B

    Hepatology Research

    Volume 43, Issue 3, March 2013, Pages: 219–227, Soon Sun Kim, Dami Lee, Myoung Hee Lee, Jae Youn Cheong and Sung Won Cho

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1872-034X.2012.01065.x

  18. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 120–127, G. V. Papatheodoridis, S. Manolakopoulos, G. Touloumi, G. Nikolopoulou, M. Raptopoulou-Gigi, C. Gogos, I. Vafiadis-Zouboulis, D. Karamanolis, A. Chouta, A. Ilias, C. Drakoulis, K. Mimidis, I. Ketikoglou, E. Manesis, M. Mela, G. Hatzis, G. N. Dalekos and for the HepNet.Greece Study Group

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jvh.12283

  19. Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir

    Journal of Viral Hepatitis

    Volume 22, Issue 8, August 2015, Pages: 675–681, L. Lu, B. Yip, H. Trinh, C. Q. Pan, S.-H. B. Han, C. C. Wong, J. Li, S. Chan, G. Krishnan, C. C. Wong and M. H. Nguyen

    Version of Record online : 24 NOV 2014, DOI: 10.1111/jvh.12368

  20. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?

    Journal of Gastroenterology and Hepatology

    Volume 24, Issue 3, March 2009, Pages: 429–435, Yoshiyuki Suzuki, Fumitaka Suzuki, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Yuzo Miyakawa and Hiromitsu Kumada

    Version of Record online : 15 FEB 2009, DOI: 10.1111/j.1440-1746.2008.05760.x